Evidence map›Paper›PMID 27493611›Full record

ArticleThe plant pathology journal2016

A Rice Gene Homologous to Arabidopsis AGD2-LIKE DEFENSE1 Participates in Disease Resistance Response against Infection with Magnaporthe oryzae.

Ga Young Jung, Ju Yeon Park, Hyo Ju Choi, Sung-Je Yoo, Jung-Kwon Park, Ho Won Jung

Abstract read
In one paragraph

Article in The plant pathology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ga Young JungDepartment of Genetic Engineering, Dong-A University, Busan 49315, Korea.
Ju Yeon ParkDepartment of Applied Biosciences, Dong-A University, Busan 49315, Korea.
Hyo Ju ChoiDepartment of Genetic Engineering, Dong-A University, Busan 49315, Korea.
Sung-Je YooDepartment of Genetic Engineering, Dong-A University, Busan 49315, Korea.
Jung-Kwon ParkDepartment of Applied Biosciences, Dong-A University, Busan 49315, Korea.
Ho Won JungDepartment of Genetic Engineering, Dong-A University, Busan 49315, Korea; Department of Applied Biosciences, Dong-A University, Busan 49315, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ALD1 (ABERRANT GROWTH AND DEATH2 [AGD2]-LIKE DEFENSE1) is one of the key defense regulators in Arabidopsis thaliana and Nicotiana benthamiana. In these model plants, ALD1 is responsible for triggering basal defense response and systemic resistance against bacterial infection. As well ALD1 is involved in the production of pipecolic acid and an unidentified compound(s) for systemic resistance and priming syndrome, respectively. These previous studies proposed that ALD1 is a potential candidate for developing genetically modified (GM) plants that may be resistant to pathogen infection. Here we introduce a role of ALD1-LIKE gene of Oryza sativa, named as OsALD1, during plant immunity. OsALD1 mRNA was strongly transcribed in the infected leaves of rice plants by Magnaporthe oryzae, the rice blast fungus. OsALD1 proteins predominantly localized at the chloroplast in the plant cells. GM rice plants over-expressing OsALD1 were resistant to the fungal infection. The stable expression of OsALD1 also triggered strong mRNA expression of PATHOGENESIS-RELATED PROTEIN1 genes in the leaves of rice plants during infection. Taken together, we conclude that OsALD1 plays a role in disease resistance response of rice against the infection with rice blast fungus.

Indexed as

AGD2-LIKE DEFENSE 1 (ALD1)disease resistance plantgenetically modified plantMagnaporthe oryzaeOryza sativa

Identifiers

PMID27493611
PMCPMC4968646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.